Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

COVID-19 Update: New CDC Guidance About the Omicron Variant

By Yvonne Puig (US), Daphne Calderon (US) & Hannah Putnam (US) on December 15, 2021
Email this postTweet this postLike this postShare this post on LinkedIn

The Centers for Disease Control and Prevention (“CDC”) reported that the Omicron variant has been detected in all but sixteen of the United States. The Delta variant continues to be the main variant circulating in the United States, however. The World Health Organization (“WHO”) reported on December 14, 2021, that seventy-seven countries have reported cases of the Omicron variant. Even still, the WHO suspects that the Omicron variant is in all countries even if it has yet to be detected. WHO Director General Dr. Tedros Adhanom Ghebreyesus urged that vaccination alone is not enough; everyone should observe social distancing, hand hygiene, proper ventilation, and all other protective measures observed throughout the pandemic.

Many unknowns remain regarding the effects of the Omicron variant. The CDC reported that the Omicron variant spreads more easily than the original COVID-19 virus but how easily it spreads compared to the Delta variant is still unknown. Individuals that are vaccinated should be protected from severe reaction to the Omicron variant, although breakthrough infections for those individuals are likely to occur. The CDC emphasized that “[v]accines remain the best public health measure to protect people from COVID-19, slow transmission, and reduce the likelihood of new variants emerging.”

Norton Rose Fulbright lawyers will continue to provide relevant updates for healthcare providers on the Health Law Pulse during the COVID-19 public health crisis.

Photo of Yvonne Puig (US) Yvonne Puig (US)

US Head of Life Sciences and Healthcare Yvonne Puig has a substantial commercial litigation practice in both state and federal courts. She represents hospitals, HMOs, managed care organizations, medical schools and other institutional health care providers and educational services companies. A partner in…

US Head of Life Sciences and Healthcare Yvonne Puig has a substantial commercial litigation practice in both state and federal courts. She represents hospitals, HMOs, managed care organizations, medical schools and other institutional health care providers and educational services companies. A partner in Norton Rose Fulbright’s Austin office, Yvonne’s practice involves commercial and health care litigation, antitrust, regulatory and compliance advice, crisis management, staff privileges, exclusive contracting and administrative law.

Read more about Yvonne Puig (US)Email
Show more Show less
Photo of Daphne Calderon (US) Daphne Calderon (US)
Read more about Daphne Calderon (US)Email
Photo of Hannah Putnam (US) Hannah Putnam (US)
Read more about Hannah Putnam (US)Email
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Health Law Pulse
  • Organization:
    Norton Rose Fulbright
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo